NRG GY033

Primary Category:

Treatment Protocols

Disease Category:

Gynecologic, Ovarian

Status:

New, Open

A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination with Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell Tumor

NCT#06169124